Mô tả
Overview of the study design and methodology for this randomized controlled trial of probiotic supplementation in IBS. The layout presents the clinical framework used to assess Bacillus coagulans efficacy across multiple outcome measures.
Figure 2
Source Paper
Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled …Cite This Figure
![Figure 2: Overview of the study design and methodology for this randomized controlled trial of probiotic supplementation in IBS. The layout presents the clinical framework used to assess Bacillus coagulans efficacy across multiple outcome measures.]() > Source: Muhammed Majeed et al. "Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predo." *Nutrition journal*, 2016. PMID: [26922379](https://pubmed.ncbi.nlm.nih.gov/26922379/)
<figure> <img src="" alt="Overview of the study design and methodology for this randomized controlled trial of probiotic supplementation in IBS. The layout presents the clinical framework used to assess Bacillus coagulans efficacy across multiple outcome measures." /> <figcaption>Figure 2. Overview of the study design and methodology for this randomized controlled trial of probiotic supplementation in IBS. The layout presents the clinical framework used to assess Bacillus coagulans efficacy across multiple outcome measures.<br> Source: Muhammed Majeed et al. "Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predo." <em>Nutrition journal</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26922379/">26922379</a></figcaption> </figure>